Annexin Pharmaceuticals Ab

Calculating rank

USPTO Granted Patents = 8

% Expired Patents = 25.0

EPO Patents = 7

Forward Citations = 0

Loading Chart...

7 inventors (with patents filed for the assignee):

Johan Frostegård (6 out of 12 patents)

Knut Pettersson (5 out of 9 patents)

Ola Camber (2 out of 4 patents)

4. Toomas Moks (2 out of 2 patents)

5. Jan Christoph Reich (2 out of 2 patents)

6. Anna Frostegård (1 out of 1 patent)

7. Divya Thiagarajan (1 out of 1 patent)

8. Anders Haegerstrand (1 patent)

9. Frostegard Johan (0 patent)

8 patents: Sort by Forward Citations

1. 11801283 - Therapeutic compositions (2023-10-31),

2. 11773134 - Process of manufacture of annexin V (2023-10-03),

3. 11472837 - Process of manufacture of annexin V (2022-10-18),

4. 9901614 - Methods for treating restenosis using annexin A5 (2018-02-27),

5. 9682122 - Compounds and methods for the treatment of vascular disease (2017-06-20),

6. 9649355 - Compounds and methods for the treatment of vascular disease (2017-05-16),

7. 9295716 - Methods for treating restenosis using annexin A5 (2016-03-29),

8. 8809497 - Compounds and methods for the treatment of vascular disease (2014-08-19),

Company Overview

Annexin Pharmaceuticals Ab is a biopharmaceutical company dedicated to developing innovative therapies in the fields of oncology and immunology. Our focus is on developing novel treatments targeting cancer and immune-related disorders. With a strong pipeline of promising drug candidates, we are committed to improving the lives of patients and transforming the landscape of healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#100 in Stockholm

#720 in Sweden

Stockholm, Sweden

Annexin Pharmaceuticals Ab

Forward Citations = 0

7 inventors:

Johan Frostegård (6 out of 12 patents)

Knut Pettersson (5 out of 9 patents)

Ola Camber (2 out of 4 patents)

4. Toomas Moks (2 out of 2 patents)

5. Jan Christoph Reich (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Annexin Pharmaceuticals Ab. Retrieved from https://idiyas.com/company/annexin-pharmaceuticals-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]